• PCV87 COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION

    May 1, 2010, 00:00

  • PCN5 ASSESSMENT OF NEUROPATHY IN CLAIMS DATA AND THE ASSOCIATION WITH DOCETAXEL (DC) AND PACLITAXEL (PC) IN ADJUVANT BREAST CANCER (BC)

    May 1, 2010, 00:00

  • PCN150 TRENDS IN USAGE AND UPTAKE OF TARGETED CANCER THERAPIES VERSUS CHEMOTHERAPIES

    May 1, 2010, 00:00

  • PIH12 DULOXETINE DOSING PATTERNS AND HEALTH CARE COSTS AMONG ELDERLY DIAGNOSED WITH FIBROMYALGIA

    May 1, 2010, 00:00

  • PND15 ECONOMICAL EVALUATION OF DIFFERENT FORMS OF BETAHISTINE IN PATIENTS WITH VERTIGO

    May 1, 2010, 00:00

  • PCN120 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR LUNG CANCER TREATMENT IN KOREA

    May 1, 2010, 00:00

  • PMH64 USE OF PATIENT SUPPORT SYSTEM TO INCREASE COMPLIANCE FOR OPIOID ADDICTED PATIENTS

    May 1, 2010, 00:00

  • PDB25 THE ECONOMIC IMPACT OF WEIGHT LOSS FOR PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS (T2DM) IN THE US

    May 1, 2010, 00:00

  • PIN11 A LONGITUDINAL DATABASE STUDY OF ECONOMIC CONSEQUENCES OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTIONS IN THE U.S.

    May 1, 2010, 00:00

  • PMH24 ASSOCIATION OF ANTIDEPRESSANT THERAPY AND BIPOLAR DISORDER (BD)-RELATED RE-HOSPITALIZATIONS AMONG PATIENTS WITH MANIC OR MIXED BD EPISODES

    May 1, 2010, 00:00

  • PMH30 COSTS ASSOCIATED WITH ANTIPSYCHOTIC MEDICATIONS AT CLINICALLY RECOMMENDED DOSES BASED ON MEDICAID CLAIMS DATA FROM EIGHT STATES

    May 1, 2010, 00:00

  • PIN26 COST EFFECTIVENESS ANALYSIS TO TREAT LATENT TUBERCULOSIS INFECTION- CAMPARING ISONIAZID, RIFAMPIN AND RIFAMPIN/PYRAZINAMIDE

    May 1, 2010, 00:00

  • PGI15 MEDICAL SERVICE UTILIZATION AND COSTS BY DISEASE SEVERITY, SUSTAINED VIRAL RESPONSE, AND GENOTYPE IN EUROPEAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS

    May 1, 2010, 00:00

  • PSS13 VALIDITY AND RELIABILITY OF THE VISUAL FUNCTION QUESTIONNAIRE UTILITY INDEX IN INDIVIDUALS WITH AGE-RELATED MACULAR DEGENERATION

    May 1, 2010, 00:00

  • PMS66 REAL-WORLD TRENDS IN THE DIAGNOSIS AND ASSESSMENT OF RHEUMATOID ARTHRITIS (RA) AMONG RHEUMATOLOGISTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCN3 RELIABILITY OF CLINICIAN VS. CLINICIAN ADVERSE SYMPTOM REPORTING

    May 1, 2010, 00:00

  • PSY12 COMPARISON OF ABSENTEEISM AND TOTAL HEALTH CARE EXPENDITURES FOR SELECT AUTO-IMMUNE INFLAMMATORY DISORDERS (AMD) PRE AND POST ANTI-TNF USE-AN EMPLOYERS PERSPECTIVE

    May 1, 2010, 00:00

  • PCV56 INCREMENTAL COSTS OF BLEEDING IN PATIENTS WITH ATRIAL FIBRILLATION WITHIN A LARGE, NATIONAL HEALTH PLAN

    May 1, 2010, 00:00

  • CV3 EFFECT OF BIVALIRUDIN ON ECONOMIC OUTCOMES OF STEMI PATIENTS IN AN OBSERVATIONAL DATASET

    May 1, 2010, 00:00

  • PMS23 ECONOMICAL EVALUATION OF ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PRS35 COMPARISON OF PATIENT REPORTED OUTCOMES BASED ON THE MINNESOTA NICOTINE WITHDRAWAL SCALE (MNWS) USING ABSTINENCE PROFILES IN TREATMENTS WITH VARENICLINE AND TRANSDERMAL NICOTINE PATCH (NRT)

    May 1, 2010, 00:00

  • PMH4 DEMOGRAPHIC RISK FACTORS AFFECTING BENZODIAZEPINE-RELATED EMERGENCY ROOM VISITS IN KANSAS CITY, MO FROM 2001 TO 2007

    May 1, 2010, 00:00

  • PSY6 IMPACT OF A PRIOR AUTHORIZATION FOR PREGABALIN ON HEALTH PLAN DRUG EXPENDITURES

    May 1, 2010, 00:00

  • PDB14 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF SAXAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES IN ARGENTINA

    May 1, 2010, 00:00

  • PSS17 IMPACT OF ADALIMUMAB ON QUALITY OF LIFE AND DEPRESSION IN PSORIASIS PATIENTS- RESULTS FROM PRIDE

    May 1, 2010, 00:00

  • PRS33 TRANSLATING THE EXACT- ENSURING CONCEPTUAL EQUIVALENCE ACROSS MULTIPLE CULTURES

    May 1, 2010, 00:00

  • PHP93 ASSESSMENT OF METABOLIC MONITORING OF PATIENTS PRESCRIBED SECOND GENERATION ANTIPSYCHOTICS (SGAS) USING ELECTRONIC MEDICAL RECORD (EMR) DATA

    May 1, 2010, 00:00

  • PHP2 VALIDITY OF THE ADHERENCE ESTIMATOR IN THE PREDICTION OF PERSISTENCE WITH CHRNONIC MEDICATIONS ASSESSED OVER M MONTHS

    May 1, 2010, 00:00

  • PHP108 THE HEALTH ECONOMIC IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN RESIDENTIAL CARE IN GERMANY

    May 1, 2010, 00:00

  • PMS5 MEDICAL COSTS FOLLOWED BY FALLS/SLIPS AT A TEACHING HOSPITAL IN JAPAN

    May 1, 2010, 00:00

  • PDB54 CLINICAL AND ECONOMIC OUTCOMES OF A DIABETES MEDICATION MANAGEMENT PROGRAM

    May 1, 2010, 00:00

  • PHP103 WHEN ARE DIAGNOSTIC LABORATORY TESTS COST-EFFECTIVE? A SYSTEMATIC REVIEW OF COST-UTILITY ANALYSES

    May 1, 2010, 00:00

  • PCV118 CHARACTERIZATION OF COMMERCIALLY INSURED PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) RECEIVING PERCUTANEOUS CORONARY INTERVENTION (PCI)

    May 1, 2010, 00:00

  • PMH33 COMPARISON OF COSTS AND HEALTH CARE UTILIZATIONS IN PHARMACOTHERAPY, PSYCHOTHERAPY, AND COMBINED THERAPY GROUPS FOR TREATMENT OF DEPRESSION

    May 1, 2010, 00:00

  • PCV86 COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA

    May 1, 2010, 00:00

  • SB4 DEALING WITH SELECTION BIAS IN NONLINEAR SETTINGS- A CASE OF COMPARATIVE EFFECTIVENESS OF STATIN PLUS FIBRATE COMBINATION THERAPY VERSUS STATIN MONOTHERAPY IN TYPE II DIABETES

    May 1, 2010, 00:00

  • PMC7 ESTIMATING TIME-PROFILED ECONOMIC BURDEN OF ILLNESS

    May 1, 2010, 00:00

  • PCV12 TRENDS IN C-REACTIVE PROTEIN SCREENING PRIOR TO STATIN USE IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCN65 A COST-EFFECTIVENESS ANALYSIS OF THE FIRST-LINE TREATMENT REGIMENS FOR MULTIPLE MYELOMA IN MACAO CHINA

    May 1, 2010, 00:00

  • PCN100 SIMILARITIES AND DIFFERENCES IN TREATMENT PATTERNS AND RESOURCE UTILISATION FOR MULTIPLE MYELOMA- A COMPARISON BETWEEN 4 NORDIC COUNTRIES

    May 1, 2010, 00:00

  • PHP85 WHEN AND HOW ARE EVIDENCE REVIEWS ON PERSONALIZED MEDICINE USED FOR HEALTH PLAN POLICY DECISIONS?

    May 1, 2010, 00:00

  • PDB4 PREVALENCE OF RENAL INSUFFICIENCY IN A COMMERICALLYINSURED POPULATION WITH TYPE 2 DIABETES MELLITUS ENROLLED IN A LARGE, US NATIONAL HEALTH PLAN

    May 1, 2010, 00:00

  • PUK19 ECONOMIC EVALUATION OF PERITONEAL DIALYSYS COMPARED WITH HEMODIALYSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE SECONDARY TO DIABETES OR HYPERTENSION IN COLOMBIA

    May 1, 2010, 00:00

  • CE2 COST-EFFECTIVENESS OF SILDENAFIL IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION IN MEXICAN ADULT PATIENTS

    May 1, 2010, 00:00

  • PCN107 EVALUATION OF QUALITY OF LIFE FOR ANTI-CANCER TREATMENT AMONGST KOREAN METASTATIC BREAST CANCER PATIENTS- A MULTICENTER, CROSS-SECTIONAL STUDY

    May 1, 2010, 00:00

  • PCN6 EVALUATION OF THE RELIABILITY OF ELECTRONIC MEDICAL RECORD DATA IN IDENTIFYING COMORBID CONDITIONS AMONG PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2010, 00:00

  • ME4 THE IMPACT OF MEDICARE PART D ON HEALTH CARE UTILIZATION AND HEALTH OF THE MEDICARE BENEFICIARIES

    May 1, 2010, 00:00

  • PCN44 ASSESSMENT OF HEALTH CARE UTILIZATION AND COST AMONG METASTATIC MELANOMA PATIENTS IN A US MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PMC29 PATIENT PREFERENCE WEIGHTS FOR BENEFIT-RISK ANALYSIS- A STATIN CASE STUDY

    May 1, 2010, 00:00

  • PCN137 CHARACTERISTICS OF PATIENTS AND PREDICTORS OF IN-HOSPITAL MORTALITY AFTER HOSPITALIZATION FOR LUNG CANCER IN WEST VIRGINIA

    May 1, 2010, 00:00

  • PIN48 USE OF AN ELECTRONIC HEALTH RECORD (EHR) DATABASE TO IDENTIFY HOSPITAL-ACQUIRED PNEUMONIA (HAP)

    May 1, 2010, 00:00

  • PRS14 THE IMPACT OF ASTHMA ON HEALTH CARE UTILIZATION AND EXPENDITURE OF PEDIATRIC PATIENTS

    May 1, 2010, 00:00

  • PHP1 MORE EFFECTIVELY ENGAGING CONSUMERS IN COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2010, 00:00

  • PND17 ECONOMIC EVALUATION OF THE IMPACT OF MEMANTINE ON TIME TO NURSING HOME ADMISSION IN THE TREATMENT OF ALZHEIMERS DISEASE

    May 1, 2010, 00:00

  • CASE4 NEW FINDINGS FROM INTEGRATING ADMINISTRATIVE AND FINANCIAL DATABASES TO ESTIMATE PRICE OF HOSPITALIZATIONS

    May 1, 2010, 00:00

  • PCV36 CARDIOVASCULAR RISK FACTORS AMONG HISPANIC AND NONHISPANIC WHITE ADULTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PHP77 AN EMPIRICAL INVESTIGATION OF MEDICAL LOSS RATIO

    May 1, 2010, 00:00

  • PMS3 A BAYESIAN ANALYSIS OF BISPHOSPHONATE EFFICACY FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS

    May 1, 2010, 00:00

  • PCN143 COST-EFFECTIVENESS OBSERVATIONS AND ONCOLOGY DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE JOINT ONCOLOGY DRUG REVIEW

    May 1, 2010, 00:00

  • PMS63 EVALUATION OF THE QUALITY AND CONTENT OF OSTEOPOROSIS PATIENT EDUCATION INFORMATION AVAILABLE ON THE INTERNET

    May 1, 2010, 00:00

  • PIH6 PREVALENCE AND PREDICTORS OF POLYPHARMACY AMONGST ELDERLY PATIENTS- A POPULATION-BASED COHORT STUDY

    May 1, 2010, 00:00

  • PHP79 INNOVATIVE PRICING AGREEMENTS IN UK NICE SUBMISSIONS

    May 1, 2010, 00:00

  • PHP48 PHYSICIANS PERCEPTION OF MEDICAID PAYMENTS AND WILLINGNESS TO ACCEPT NEW MEDICAID PATIENTS

    May 1, 2010, 00:00

  • PSY9 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PSY37 COMPARING THE TIME TRADEOFF (TTO), THE VISUAL ANALOGUE SCALE (VAS) AND THE EQ-5D VALUE-SETS IN PATIENTS TREATED WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) OR POST-HERPETIC NEURALGIA (PHN)

    May 1, 2010, 00:00

  • PMH34 DIRECT HEALTH CARE COSTS AMONG PATIENTS WITH BIPOLAR DISORDER WHO INITIATED THERAPY WITH ARIPIPRAZOLE OR QUETIAPINE XR

    May 1, 2010, 00:00

  • PCN21 REAL-WORLD CLINICAL OUTCOMES OF PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER - RESULTS FROM A US LOCAL ONCOLOGY PRACTICE

    May 1, 2010, 00:00

  • PCV147 NOVEL QUALITY ASSURANCE ANALYSIS REVEALS PREVIOUSLY UNDETECTED DEFICIENCIES IN A POINT OF CARE DEVICE THAT MEASURES THE INTERNATIONAL NORMALIZED RATIO

    May 1, 2010, 00:00

  • PMC15 SYNCHRONIZATION OF RANDOM NUMBER STREAMS GREATLY ENHANCES EFFICIENCY OF PROBABILISTIC MODELS

    May 1, 2010, 00:00

  • PHP99 DESCRIPTION AND EVALUATION OF THE KNOWLEDGE OF THE BRASILIA POPULATION FOR THE POLITICS OF ECONOMIC MEDICINE REGULATION IN BRAZIL

    May 1, 2010, 00:00

  • PMH84 COST OF PHARMACEUTICAL CARE IN PATIENTS WITH METABOLIC SYNDROMES CAUSED BY ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PIH5 DIAGNOSIS AND TREATMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER AND DEPRESSION/ANXIETY

    May 1, 2010, 00:00

  • PMC28 INITIAL EXPERIENCE WITH THE PROMIS MEASUREMENT SYSTEM IN CLINICAL POPULATIONS

    May 1, 2010, 00:00

  • PIH22 CONSTRUCT VALIDITY OF THE BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX

    May 1, 2010, 00:00

  • PCN26 BUDGET IMPACT ANALYSIS OF AN ORGANIZED BREAST CANCER SCREENING PROGRAM BASED ON ANNUAL MAMOGRAPHY FOR COLOMBIAN WOMEN

    May 1, 2010, 00:00

  • PMH26 A COMPARISON OF TRANSITIONS BETWEEN HEALTH STATES AND INSTITUTIONALIZATION AMONG ALZHEIMERS DISEASE DEMENTIA PATIENTS USING THE NACC-UDS DATABASE

    May 1, 2010, 00:00

  • PSY15 STUDY OF FREQUENCY OF USE AND COSTS OF PATIENTS WITH CHRONIC PAIN AND NEUROPATHIC PAIN IN COLOMBIA FROM THIRD PARTY PAYERS PERSPECTIVE

    May 1, 2010, 00:00

  • PSY27 COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN ARGENTINA

    May 1, 2010, 00:00

  • PHP68 CONSUMERS KNOWLEDGE OF GENERIC OTCS- A PHARMACIST INTERVENTION STUDY

    May 1, 2010, 00:00

  • PHP25 ASSESSING TRENDS IN UTILIZATION AND COST OF THE SIX PROTECTED MEDICATION CLASSES IN THE PART D PROGRAM

    May 1, 2010, 00:00

  • PMC22 THE IMPACT OF A HOST COUNTRYS CULTURE ON IMMIGRANT LANGUAGE

    May 1, 2010, 00:00

  • PIN20 ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE WITHIN THE PRIVATE MARKET IN BRAZIL

    May 1, 2010, 00:00

  • PMH41 THE SOCIETAL COST OF SCHIZOPHRENIA IN SWEDEN

    May 1, 2010, 00:00

  • PGI13 THE DISEASE BURDEN OF IRRITABLE BOWEL SYNDROME IN KOREA

    May 1, 2010, 00:00

  • PCN118 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR STOMACH CANCER TREATMENT IN KOREA

    May 1, 2010, 00:00

  • PIN23 COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINE POLYVALENT (PPSV23) IN ADULTS OLDER THAN 60 YEARS OLD IN COLOMBIA

    May 1, 2010, 00:00

  • UT1 ASSOCIATION BETWEEN UTILITY AND TREATMENT AMONG PROSTATE CANCER PATIENTS

    May 1, 2010, 00:00

  • PMC27 HARMONISATION AS PART OF THE TRANSLATION AND LINGUISTIC PROCESS- WHAT IS THE OPTIMAL METHOD?

    May 1, 2010, 00:00

  • PCN73 COST-EFFECTIVENESS ANALYSIS OF MULTIMODAL SCREENING FOR OVARIAN CANCER

    May 1, 2010, 00:00

  • PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)- RESULTS FROM A MEDICAL CHART REVIEW STUDY

    May 1, 2010, 00:00

  • PCN37 BURDEN OF INPATIENT CASES OF ACUTE EXACERBATIONS OF COPD WITH LUNG CANCER IN THE UNITED STATES IN 2006

    May 1, 2010, 00:00

  • PCN11 ASSESSING THE TREATMENT EFFECT OF RASBURICASE ALONE VERSUS RASBURICASE AND ALLOPURINOL COMBINATION THERAPY USING PROPENSITY SCORES

    May 1, 2010, 00:00

  • PND4 ESTIMATED COST SAVINGS WHEN TREATING RESTLESS LEGS SYNDROME (RLS) WITH GABAPENTIN ENACARBIL IN THE US

    May 1, 2010, 00:00

  • CV1 PERIOPERATIVE BLOOD PRESSURE CONTROL DURING CARDIAC SURGERY REDUCES HOSPITALIZATION COSTS

    May 1, 2010, 00:00

  • PCV60 SYSTEMATIC REVIEW OF THE ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM TREATMENT

    May 1, 2010, 00:00

  • PMH54 ECONOMIC EVALUATION OF ESCITALOPRAM TO TREAT MAJOR DEPRESSIVE DISORDER

    May 1, 2010, 00:00

  • PHP87 DECISION CRITERIA FOR TECHNOLOGY ACQUISITION IN RADIOONCOLOGY-WHAT REALLY MATTERS?

    May 1, 2010, 00:00

  • HE4 CHARACTERIZATION OF FREQUENT HOSPITAL EMERGENCY DEPARTMENT (ED) USE BY UN- OR UNDERINSURED PERSONS

    May 1, 2010, 00:00

  • PGI2 ADVERSE EVENTS OF PROMETHAZINE AND ONDANSETRON IN YOUNG CHILDREN AND WOMEN OF CHILD-BEARING AGE- A PHARMACOVIGILANCE STUDY BASED ON THE FDA ADVERSE EVENT REPORTING SYSTEM

    May 1, 2010, 00:00

  • PDB57 IMPROVING CLINICAL OUTCOMES FOR EMPLOYEES PARTICIPATING IN A PHARMACIST PROVIDED MTM

    May 1, 2010, 00:00

  • PCV106 PREDICTORS OF CLOPIDOGREL USE AND ADHERENCE FOR PATIENTS WITH ACUTE CORONARY SYNDROMES IN A LARGE EMPLOYER-BASED CLAIMS DATABASE

    May 1, 2010, 00:00

  • PCV91 HEALTH CARE RESOURCE UTILIZATION AMONG ADULTS WITH TYPE 2 DIABETES MELLITUS, HYPERTENSION, AND OBESITY

    May 1, 2010, 00:00

  • PSS2 RETURN ON INVESTMENT OF ABLATIVE FRACTIONAL LASERS

    May 1, 2010, 00:00

  • PMS52 BISPHOSPHONATE THERAPY IN OSTEOPOROSIS- AN ANALYSIS FOCUSING ON DRUG CLAIMS BY SENIORS 2001 TO 2007

    May 1, 2010, 00:00

  • PIH36 BILLING PATTERNS FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER

    May 1, 2010, 00:00

  • PDB77 IDENTIFYING THE UNDERLYING FACTORS FOR DIABETES CARE AND ATTITUDES

    May 1, 2010, 00:00

  • HE1 COST-EFFECTIVENESS OF 1ST LINE CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER AMONG PATIENTS RECEIVING CARE IN THE OUTPATIENT COMMUNITY SETTING

    May 1, 2010, 00:00

  • PCN142 EVALUATING COMPARATIVE EFFECTIVENESS RESEARCH FOR ONCOLOGY IN THE US- AN ANALYSIS BASED ON LESSONS FROM HEALTH TECHNOLOGY ASSESSMENTS IN EUROPE

    May 1, 2010, 00:00

  • PCN138 THE FINANCIAL EFFECT OF THE INTRODUCTION OF PERFORMANCEVOLUME LIMIT (PVL) ON THE HUNGARIAN ONCOLOGY CARE

    May 1, 2010, 00:00

  • PIN9 COST-OF-ILLNESS OF CHRONIC HEPATITIS B INFECTION IN VIETNAM

    May 1, 2010, 00:00

  • PGI22 EVALUATION OF COST-EFFECTIVENESS OF CHRONIC HEPATITIS B TREATMENTS- ENTECAVIR AND TELBIVUDINE

    May 1, 2010, 00:00

  • PCN157 METHODOLOGIC ISSUES OF IDENTIFYING FEBRILE NEUTROPENIA PATIENTS USING MEDICAL CLAIM DATA

    May 1, 2010, 00:00

  • PND16 COST SAVING OPPORTUNITY OF POTENTIAL PHARMACIST-INITIATED IV-TO-PO LEVETIRACETAM SWITCHES- A PREDICTION MODEL BASED ON REAL-WORLD DATA

    May 1, 2010, 00:00

  • PUK18 RENAL TRANSPLANTATION VS HEMODIALYSIS-COST EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • PCV47 ECONOMIC EVALUATION ON THE USE OF LEVOSIMENDAN IN PATIENTS WITH ACCUTE HEART FAILURE (AHF) IN THE MEXICAN CONTEXT

    May 1, 2010, 00:00

  • PND2 THE VALUE OF A PREDICTIVE DIAGNOSTIC BLOOD TEST IN MULTIPLE SCLEROSIS (MS)

    May 1, 2010, 00:00

  • PMH60 ADHERENCE TO MEDICATION FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)-DOES THE TIMEFRAME MATTER?

    May 1, 2010, 00:00

  • PIH33 PREDICTION OF DEPRESSION IN LATE PREGNANCY

    May 1, 2010, 00:00

  • PCV137 ANALYSIS OF HEALTH CARE OUTCOME FOR CONGESTIVE HEART FAILURE (CHF) PATIENTS

    May 1, 2010, 00:00

  • PCV136 PRIORITY-SETTING FOR COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2010, 00:00

  • CN3 DIRECT MEDICAL COSTS OF TREATMENT OF METASTATIC BREAST CANCER AFTER ANTHRACYCLINES AND TAXANES FAILURE FROM THE MEXICAN PUBLIC HEALTH SYSTEM PERSPECTIVE

    May 1, 2010, 00:00

  • PMC42 EXAMINATION OF THE DIFFERENCES IN PATIENT SATISFACTION BETWEEN FIRST VISIT AND RETURN VISITS- ANALYSIS OF A USA SELF-REPORTED SURVEY DATA

    May 1, 2010, 00:00

  • PIN49 APPLICATION OF A NATIONAL PRESCRIPTION DATABASE TO DEVISE A PREDICTIVE MODEL FOR TAILORING HIV/AIDS THERAPEUTIC MANAGEMENT

    May 1, 2010, 00:00

  • PCV13 THE UTILISATION AND EFFECTIVENESS OF ANTITHROMBOTIC AGENTS FOR PREVENTING DEEP VEIN THROMBOSIS AFTER TOTAL HIP REPLACEMENT-A CASE STUDY IN SOUTHERN TAIWAN

    May 1, 2010, 00:00

  • PRS18 ASSESSMENT OF THE CLINICAL AND ECONOMIC IMPACT OF AIR LEAKS DURING POST-OPERATIVE PULMONARY SURGERY

    May 1, 2010, 00:00

  • PMS72 A NEW METHODOLOGY TO ASSESS CLINICAL CHANGE USING CHARTS IN RHEUMATOID ARTHRITIS (RA) PATIENTS ON TNF BLOCKERS

    May 1, 2010, 00:00

  • PCN117 QUALITY OF LIFE SCALE FOR PATIENTS WITH HAND-FOOT SYNDROME - FIRST RESULTS

    May 1, 2010, 00:00

  • PCN64 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PUBLIC HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PRS32 RELATIONSHIP OF COST-SHARING LEVELS TO ADHERENCE WITH DUAL-CONTROLLER THERAPY AMONG ASTHMA PATIENTS

    May 1, 2010, 00:00

  • PSY10 THE DIRECT MEDICAL COSTS OF PSORIASIS- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PCV90 COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN SWEDEN

    May 1, 2010, 00:00

  • PCV27 THE USE OF ALENDRONATE AND CARDIOVASCULAR DISEASES

    May 1, 2010, 00:00

  • PCN126 INEQUALITY OF FORMULARY COVERAGE OF COLORECTAL CANCER DRUGS AMONG TAIWANS NATIONAL HEALTH INSURANCE HOSPITALS

    May 1, 2010, 00:00

  • PMS55 RACIAL AND ETHNIC DISPARITIES IN TOTAL HIP REPLACEMENT SURGERY

    May 1, 2010, 00:00

  • PCN8 IMPACT OF 5-HT3-RECEPTOR ANTAGONIST STEP THERAPY ON CHEMOTHERAPY INDUCED NAUSEA AND VOMITING ASSOCIATED HOSPITAL AND EMERGENCY ROOM EVENTS

    May 1, 2010, 00:00

  • PCN127 EFFECT OF ACCESS TO CANCER CARE ON AGE-SPECIFIC UTILIZATION OF CHEMOTHERAPY AMONG ELDERLY WOMEN WITH METASTATIC BREAST CANCER

    May 1, 2010, 00:00

  • PHP52 PREVALENCE AND PREDICTORS OF UNINTENTIONAL NON-ADHERENCE AMONG ADULTS WITH CHRONIC DISEASE WHO SELF-IDENTIFY AS BEING ADHERENT TO PRESCRIPTION MEDICATIONS

    May 1, 2010, 00:00

  • SB1 EXPENDITURE OF DISEASE MODIFYING ANTI-RHEUMATOID TREATMENT-LAGGED TREATMENTS AS INSTRUMENTAL VARIABLES IN PANEL DATA

    May 1, 2010, 00:00

  • PCN98 COST-EFFECTIVENESS OF ADJUVANT THERAPY WITH TRASTUZUMAB IN THE TREATMENT OF EARLY BREAST CANCER (EBC) IN ROMANIA

    May 1, 2010, 00:00

  • PND28 CROSS CULTURAL EVALUATION OF THE SHORT FORM 8 ITEM PARKINSONS DISEASE QUESTIONNAIRE- RESULTS FROM AMERICA, CANADA, JAPAN, ITALY AND SPAIN

    May 1, 2010, 00:00

  • PIN16 COST-EFFECTIVENESS ANALYSIS OF MICAFUNGIN VERSUS LIPOSOMAL AMPHOTERICIN B IN THE TREATMENT OF PAEDIATRIC PATIENTS WITH SYSTEMIC CANDIDA INFECTIONS

    May 1, 2010, 00:00

  • PSY3 CENTRAL VENOUS LINE INFECTIONS IN PATIENTS WITH HEMOPHILIA AND HOME CARE SERVICES

    May 1, 2010, 00:00

  • PND9 HEALTH CARE COSTS STRATIFIED BY EPILEPSY SEVERITY IN A US COMMERCIALLY INSURED SETTING

    May 1, 2010, 00:00

  • PCV85 COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME (ACS) PATIENTS IN SPAIN

    May 1, 2010, 00:00

  • PSY46 EFFECT OF ACUTE BLEEDING EPISODES ON QUALITY OF LIFE (QOL) IN PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR FAMILIES- OBSERVATIONS OF BLEED VS. NON-BLEED DAY QOL FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA ...

    May 1, 2010, 00:00

  • CM1 ADHERENCE, DISCONTINUATION, AND SWITCHING OF BIOLOGIC THERAPIES IN MEDICAID ENROLLEES WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PMH16 THE COMPARATIVE EFFICACY AND SAFETY OF ADJUNCTIVE ANTIPSYCHOTICS IN MAJOR DEPRESSIVE DISORDER PATIENTS THAT FAILED TO RESPOND TO CONVENTIONAL ANTIDEPRESSANTS

    May 1, 2010, 00:00

  • PHP17 WHAT FACTORS PREDICT FAVORABLE MEDICARE COVERAGE?

    May 1, 2010, 00:00

  • PCN148 YEAR ONE EVALUATION OF PARTICIPATION AND COMPLIANCE IN REGIONAL PAY FOR QUALITY (P4Q) ONCOLOGY PROGRAM

    May 1, 2010, 00:00

  • PIH19 IMPACT OF SEVERITY DIFFERENCES ON LOGICAL INCONSISTENCIES IN VALUES FOR EQ-5D HEALTH STATES

    May 1, 2010, 00:00

  • PCV3 ESTIMATION OF ADVERSE EVENTS RELATED WITH MEDICARE PATIENTS WHO UNDERWENT HIP FRACTURE SURGERY AND SUFFERED VENOUS THROMBOEMBOLISM VERSUS NO VENOUS THROMBOEMBOLISM

    May 1, 2010, 00:00

  • PSY22 COST-EFFECTIVENESS OF STRATEGIES FOR DIAGNOSING HEPARIN-INDUCED THROMBOCYTOPENIA

    May 1, 2010, 00:00

  • PCN13 TAXANE USE AND NEUROPATHY IN EARLY STAGE BREAST CANCER PATIENTS - RESULTS FROM A US COMMUNITY ONCOLOGY CENTER

    May 1, 2010, 00:00

  • SB3 COMPARISON OF DIFFERENT PROPENSITY SCORE MATCHING METHODS IN ELDERLY ANTIPSYCHOTIC USERS

    May 1, 2010, 00:00

  • PHP23 A TREND ANALYSIS OF DISCONTINUED NEW MOLECULAR ENTITIES IN THE US

    May 1, 2010, 00:00

  • PCN109 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

    May 1, 2010, 00:00

  • PCV68 COST-EFFECTIVENESS OF GENOTYPE-DRIVEN ANTIPLATELET THERAPY FOR SECONDARY PREVENTION AFTER ACUTE CORONARY SYNDROME

    May 1, 2010, 00:00

  • PND38 SOCIODEMOGRAPHIC PATTERNS OF INSOMNIA DRUG PRESCRIPTIONS

    May 1, 2010, 00:00

  • PMC2 REVIEW OF PHARMACOECONOMIC RECOMMENDATIONS FOR THE DEFINITION OF A SOCIETAL PERSPECTIVE

    May 1, 2010, 00:00

  • PIH18 ANALYSIS OF NECROTIZING ENTEROCOLITIS COSTS AMONG EXTREMELY PRETERM INFANTS FED EXCLUSIVELY HUMAN-MILK BASED DIET VS. HUMAN-MILK FORTIFIED WITH BOVINE-MILK BASED SUPPLEMENTS

    May 1, 2010, 00:00

  • PCV29 THROMBOPROPHYLAXIS OF PATIENTS RECEIVING TOTAL KNEE REPLACEMENT- 1998-2002 VERSUS 2003-2007

    May 1, 2010, 00:00

  • PCN28 BUDGET IMPACT ANALYSIS OF NEW PROSTATE-SPECIFIC ANTIGEN ASSAY AND INDEX FOR PROSTATE CANCER DETECTION

    May 1, 2010, 00:00

  • PCN33 OPEN VERSUS LAPAROSCOPIC PROCEDURES FOR COLECTOMY SURGERY FOR PATIENTS WITH COLON RECTAL CANCER- AN ANALYSIS OF OPPORTUNITY COSTS, UNDER THE PERSPECTIVE OF A PRIVATE HOSPITAL IN BRAZIL

    May 1, 2010, 00:00

  • PCV111 ANALYZING THE RELATIONSHIP BETWEEN CHANGES IN PROS AND CLINICAL ENDPOINTS

    May 1, 2010, 00:00

  • PCN32 RECENT ERYTHROPOIESIS STIMULATING AGENT (ESA) UTILIZATION AND COSTS IN MEDICARE PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY (CRC)

    May 1, 2010, 00:00

  • PDB37 THE IMPACT OF DIABETES ON WORKPLACE ABSENTEEISM AND PRESENTEEISM- A COMPARISON OF CHINA AND JAPAN

    May 1, 2010, 00:00

  • PDB10 SURVIVAL AS A FUNCTION OF HBA1C IN PEOPLE WITH TYPE 2 DIABETES- A RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PCV11 IDENTIFYING RISK FACTORS ASSOCIATED WITH DISEASE BURDEN IN PATIENTS WITH TYPE II DIABETES AND COMORBID CARDIOVASCULAR DISEASE

    May 1, 2010, 00:00

  • PIH23 OVERVIEW OF THE DEVELOPMENT PHASES OF THE OXFORD ANKLE FOOT QUESTIONNAIRE FOR CHILDREN

    May 1, 2010, 00:00

  • PMC48 METHODS FOR IDENTIFYING CASE REPORTS OF SUSPECTED ADVERSE DRUG REACTIONS- AN EVALUATION OF THE EFFICIENCY OF ALTERNATIVE SEARCH STRATEGIES IN MEDLINE AND EMBASE

    May 1, 2010, 00:00

  • PCV114 HEALTH-RELATED QUALITY OF LIFE AMONG WOMEN WITH CORONARY ARTERY DISEASE TREATED WITH PSYCHOTROPIC MEDICATIONS

    May 1, 2010, 00:00

  • PCV67 EXPLORATORIES COST-CONSEQUENCE AND BUDGET IMPACT ANALYSIS OF SIROLIMUS-ELUTING STENT VS. ZOTAROLIMUSELUTING STENT FOCUSED ON THE RESTENOSIS AFTER DRUGELUTING STENT PLACEMENT UNDER THE PERSPECTIVE OF A BRAZILIAN PRIVATE PAYER

    May 1, 2010, 00:00

  • PSY32 COST-EFFECT ANALYSIS OF THE USE OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES COMPARED TO FLUCONAZOLE AND ITRACONAZOLE IN PATIENTS WITH PRONOUNCED NEUTROPENIA

    May 1, 2010, 00:00

  • PDB67 ECONOMIC EVALUATION OF TYPE 2 DIABETES - IMPACT OF PRICING AND REIMBURSEMENT REFORMS

    May 1, 2010, 00:00

  • PMC45 INTEGRATED INTERPRETATION OF KAPPA WITH SENSITIVITY AND SPECIFICITY

    May 1, 2010, 00:00

  • PCV23 REDUCTIONS IN CORONARY HEART DISEASE MORTALITY ASSOCIATED WITH CHANGES IN RISK FACTORS AND TREATMENT UPTAKES IN ONTARIO BETWEEN 1994 AND 2005

    May 1, 2010, 00:00

  • PCN83 COST-EFFECTIVENESS OF LENOGRASTYM ON NEUTROPENIA DURATION IN ADULTS RECEIVING CHEMOTHERAPY FOR SOLID TUMORS OR LYMPHOMAS

    May 1, 2010, 00:00

  • PUK6 FIVE-YEAR BUDGET IMPACT ANALYSIS OF ONCE-DAILY VERSUS TWICE-DAILY TACROLIMUS, IN PATIENTS UNDERGOING RENAL TRANSPLANT IN THE UNITED KINGDOM

    May 1, 2010, 00:00

  • PHP101 DIFFERENCES IN CLINICIAN REPORTED EASE OF USE BETWEEN 2 HEMOSTASIS TREATMENT METHODS- RESULTS FROM A RANDOMIZED CONTROLLED STUDY

    May 1, 2010, 00:00

  • PCV108 PATTERNS AND PREDICTORS OF PERSISTENCE OF WARFARIN AND OTHER COMMONLY-UTILIZED CHRONIC MEDICATIONS AMONG PATIENTS WITH ATRIAL FIBRILLATION

    May 1, 2010, 00:00

  • PUK15 COST-EFFECTIVENESS ANALYSIS OF THREE MONTHS TREATMENT WITH FESOTERODINE COMPARED TO GENERIC OXYBUTYNIN EXTENDED-RELEASE IN WOMEN WITH URINARY INCONTINENCE FROM A THIRD PARTY PAYER PERSPECTIVE

    May 1, 2010, 00:00

  • PMH9 PATIENTS BENEFITS PREDICT SUBSEQUENT RESPONSE IN THE TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PDB28 COST-EFFECTIVENESS OF SOMASTATIN ANALOGUES FOR THE TREATMENT OF ACROMEGALY IN COLOMBIA

    May 1, 2010, 00:00

  • PHP104 THE BUDGET IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN THE COMMUNITY SETTING IN THE NETHERLANDS

    May 1, 2010, 00:00

  • PMH69 THE EFFECT OF A TELEPHONIC PATIENT SUPPORT PROGRAM ON TREATMENT OUTCOMES AMONG A SAMPLE OF OPIOID DEPENDNCE PATIENTS- ONE YEAR FOLLOW-UP

    May 1, 2010, 00:00

  • PCV150 UTILIZATION OF SECONDARY PREVENTIVE MEDICATIONS FOLLOWING ACUTE MYOCARDIAL INFARCTION (AMI)- A RETROSPECTIVE COHORT ANALYSIS OF A MEDICAID POPULATION

    May 1, 2010, 00:00

  • PMH42 ECONOMIC COSTS OF ABUSE AND MISUSE OF PRESCRIPTION OPIOIDS

    May 1, 2010, 00:00

  • PCN154 COLORECTAL CANCER HOSPITAL ADMISSIONS IN WEST VIRGINIA FROM 2003 TO 2007

    May 1, 2010, 00:00

  • PDB49 AGE-SPECIFIC ORIGINALS- USING THE PEDIATRIC QUALITY OF LIFE) DIABETES MODULE TO STUDY SIMILARITIES AND DIFFERENCES IN TARGET LANGUAGES

    May 1, 2010, 00:00

  • PHP97 MEDICATION THERAPY QUALITY- A REVIEW OF MEASURES AND CONCEPTUAL FRAMEWORK TO ALIGN PHYSICIANS AND PHARMACISTS

    May 1, 2010, 00:00

  • PHP89 THE INFLUENCE OF SAFETY ISSUES ON DECISIONS OF CONSULTATIVE COUNCIL OF THE AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND

    May 1, 2010, 00:00

  • PIN22 COST-EFFECTIVENESS ANALYSIS OF LINEZOLID VS VANCOMYCIN IN EMPIRIC TREATING MECHANIC VENTILATION-ASSOCIATED PNEUMONIA BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (VAP-MRSA) IN COLOMBIA

    May 1, 2010, 00:00

  • PSY14 COMPARISON OF ABSENTEEISM AND TOTAL HEALTH CARE EXPENDITURES FOR INFLAMMATORY BOWEL DISEASE PRE AND POST ANTI-TNF USE

    May 1, 2010, 00:00

  • PCV120 IMPACT OF THE MEDICARE PART D DONUT-HOLE ON PATIENTS WITH HYPERTENSION OR HYPERLIPIDEMIA

    May 1, 2010, 00:00

  • PMS25 A PHARMACOECONOMIC REVIEW OF ECONOMIC ANALYSES OF BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDILITIS

    May 1, 2010, 00:00

  • PMC32 PATIENT SATISFACTION COMPARISONS BETWEEN PEDIATRICIANS AND OTHER PCPS- A MULTILEVEL CROSS-NATIONAL WEB BASED SURVEY STUDY

    May 1, 2010, 00:00

  • PCN34 ECONOMIC BURDEN OF MYELODYSPLASTIC SYNDROMES AMONG US MEDICARE BENEFICIARIES- INCREASED COSTS IN TRANSFUSION DEPENDENT PATIENTS

    May 1, 2010, 00:00

  • PMH87 NATIONAL TRENDS IN PRESCRIBING ANTIDEPRESSANTS FOR DEPRESSION-BEFORE AND AFTER FDA ADVISORY ON RISK OF SUICIDALITY AMONG CHILDREN AND ADOLESCENTS

    May 1, 2010, 00:00

  • PRS34 EVALUATING PEOPLES PREFERENCES FOR PREVENTIVE TREATMENT OF LATENT TUBERCULOSIS INFECTION USING A DISCRETE CHOICE EXPERIMENT

    May 1, 2010, 00:00

  • PMC19 DIMENSIONS CHARACTERIZING GOOD HEALTH BY CHINESE IN CHINA

    May 1, 2010, 00:00

  • PCN144 COMPARITIVE KNOWLEDGE OF BREAST SELF EXAMINATION IN MIDWIFERY AND NURSING STUDENTS IN ISLAMIC AZAD UNIVERSITY KARAJ BRANCH

    May 1, 2010, 00:00

  • PMH76 FUNCTIONAL IMPAIRMENT IN CHILDREN AND ADOLESCENTS WITH DEPRESSION

    May 1, 2010, 00:00

  • PCV98 ADHERENCE TO LIPID LOWERING THERAPIES AS A PREDICTOR OF CHOLESTEROL OUTCOMES- A LITERATURE REVIEW

    May 1, 2010, 00:00

  • PGI12 FUNCTIONAL DYSPEPSIA DECREASE PRODUCTIVITY AND INCREASED MEDICAL COSTS

    May 1, 2010, 00:00

  • PCN121 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR LIVER CANCER TREATMENT IN KOREA

    May 1, 2010, 00:00

  • PCV104 AN ASSESSMENT OF ADHERENCE TO SINGLE-PILL VERSUS MULTI-PILL COMBINATION LIPID-MODIFYING THERAPIES AMONG PATIENTS WITH MIXED DYSLIPIDEMIA IN A MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PMS38 PREFERENCES AND WILLINGNESS TO PAY FOR OSTEOARTHRITIS TREATMENTS AMONG THE MEDICARE POPULATION

    May 1, 2010, 00:00

  • PHP116 ADVERSE DRUG REACTIONS OF 33 VARIETIES OF TRADITIONAL CHINESE MEDICINE INJECTIONS ON THE NATIONAL ESSENTIAL MEDICINES LIST (2004 EDITION) OF CHINA- AN OVERVIEW ON PUBLISHED LITERATURES

    May 1, 2010, 00:00

  • PDB19 COMPLICATIONS OF TYPE II DIABETES AND THEIR COST

    May 1, 2010, 00:00

  • PIH26 HEALTH RELATED QUALITY OF LIFE AMONG PARENTS WITH CHILDREN DIAGNOSED WITH A NEURO-DEVELOPMENTAL DISORDER

    May 1, 2010, 00:00

  • PDB30 COST-EFFECTIVENESS ANALYSIS OF THE DIABETES MEDICATIONS IN MEDICARE WITH SAS

    May 1, 2010, 00:00

  • PR4 ARE HEALTH STATES 'TIMELESS'? A TEST OF THE UTILITY INDEPENDENCE ASSUMPTION- COMPARING A REPEATED MEASURES DESIGN AND LATENT GROWTH MODELING

    May 1, 2010, 00:00

  • PHP31 COMPUTERIZED INTERVENTIONS TO OBTAIN INDICATION INFORMATION FOR INPATIENT PRESCRIPTIONS- A PILOT STUDY IN DRUGS FREQUENTLY USED OFF-LABEL

    May 1, 2010, 00:00

  • PCV49 COMPARATIVE EFFECTIVENESS OF LOW-MOLECULAR-WEIGHTHEPARINS- META-ANALYSIS AND PHARMACOECONOMIC ASSAY

    May 1, 2010, 00:00

  • PIH1 THE NATIONAL BURDEN OF PEDIATRIC ADVERSE DRUG EVENTS- A CASE-CONTROL STUDY USING THE 2006 KIDS INPATIENT DATABASE

    May 1, 2010, 00:00

  • PCN19 BREAST CANCER PATIENTS ARE TWICE AS LIKE TO DEVELOP ARTERIAL THROMBOEMBOLIC EVENTS AFTER DIAGNOSIS COMPARED TO CANCER-FREE WOMEN

    May 1, 2010, 00:00

  • CN4 USING QALYS IN CANCER- WHAT ARE THE METHODOLOGICAL LIMITATIONS?

    May 1, 2010, 00:00

  • PCN55 COSTS ASSOCIATED TO THE TREATMENT OF DIFFERENT STAGES OF MEXICAN PATIENTS WITH NON-HODGKIN LYMPHOMA

    May 1, 2010, 00:00

  • PUK23 ADHERENCE TO A GUIDELINE FOR ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE

    May 1, 2010, 00:00

  • PSY48 THE VALUE TO PATIENTS OF TREATING PLAQUE PSORIASIS

    May 1, 2010, 00:00

  • PMS39 ACUPUNCTURE OR PHYSICAL THERAPY? LOW-BACK PAIN PATIENTS CHOICE-A QUALITATIVE STUDY IN A GENERAL HOSPITAL, CHINA

    May 1, 2010, 00:00

  • PHP112 TRANSPLANT IMMUNOSUPPRESSIVE DRUG EXPENDITURE BY U.S. MEDICAID PROGRAMS AND UTILIZATION AMONG BENEFICIARIES- A TREND ANALYSIS FROM 1991 TO 2007

    May 1, 2010, 00:00

  • PIH16 COST-EFFECTIVENESS ANALYSIS FOR TREATMENT OF SYMPTOMATIC UTERINE FIBROIDS AMONG PREMENOPAUSAL WOMEN SEEKING TO RETAIN UTERUS

    May 1, 2010, 00:00

  • PCV22 OUTCOMES ANALYSIS OF PROFILACTICAL HEALTH CARE PROGRAMS, BASED ON 'HEART VESSEL PROPHYLACTIC PROGRAM' FOR 40 AND 50 YEAR OLD RESIDENTS OF WROCLAW CITY

    May 1, 2010, 00:00

  • PMH5 INFLUENCE OF PSYCHIATRIC COMORBIDITY AND POLYPHARMACY ON HOSPITALIZATION AND EXPENDITURES AMONG SECOND GENERATION ANTIPSYCHOTIC USERS WITH METABOLIC SYNDROME

    May 1, 2010, 00:00

  • PSY7 ECONOMIC VALUE OF LIDOCAINE PATCH 5 VS. GABAPENTIN OR PREGABALIN IN MEDICAID PATIENTS WITH POST HERPETIC NEURALGIA

    May 1, 2010, 00:00

  • PND26 VALIDATING USE OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE VERSION 2.1 (MSQ) ACROSS MIGRAINE DISORDERS

    May 1, 2010, 00:00

  • TR2 RECENT TRENDS IN EMPLOYER HEALTH CARE SPENDING BY DISEASE

    May 1, 2010, 00:00

  • PND3 GASTROINTESTINAL DISORDERS IN PATIENTS WITH PARKINSONS DISEASE- A DOUBLE-EDGED SWORD

    May 1, 2010, 00:00

  • PRS48 ASSESSING THE TIME-DEPENDENT NATURE OF COMORBIDITY INFLUENCE IN COPD

    May 1, 2010, 00:00

  • PCV135 TREATMENT PATTERNS IN ATRIAL FIBRILLATION- AGENTS USED IN CURRENT PATIENT MANAGEMENT

    May 1, 2010, 00:00

  • PRS15 ECONOMIC BURDEN OF ANAPHYLAXIS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PMS47 UNDERUSE OF BMD MEASUREMENTS AND BISPHOSPHONATE TREATMENT IN WOMAN OVER AGE 50 WITH OSTEOPOROSIS IN A NATIONALLY-REPRESENTATIVE EMR DATABASE

    May 1, 2010, 00:00

  • UT3 RELIABILITY OF HEALTH UTILITIES INDEX (HUI) SCORES- PATIENT AND PARENT INTER-RATER AGREEMENT ACROSS TWO CLINICAL TRIALS OF TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN CHILDHOOD

    May 1, 2010, 00:00

  • PMH8 IMPROVED TREATMENT OUTCOMES FOLLOWING A SWITCH FROM RISPERIDONE TO OLANZAPINE IN A 1-YEAR NATURALISTIC STUDY OF SCHIZOPHRENIA PATIENTS IN JAPAN

    May 1, 2010, 00:00

  • PSY56 INFLIXIMAB INDUCTION PATTERNS AND THE IMPACT ON MAINTENANCE THERAPY PATTERNS

    May 1, 2010, 00:00

  • PCN59 THE POTENTIAL ECONOMIC BENEFITS PROVIDED BY COMBINING CISPLATIN WITH SRC INHIBITOR KX1-004 FOR CANCER REGIMENS

    May 1, 2010, 00:00

  • PCV154 USING DIFFERENT MEASURES TO DETERMINE TIME IN THERAPEUTIC INR RANGE AMONG WARFARIN-TREATED PATIENTS FOLLOWING TOTAL HIP OR KNEE REPLACEMENT

    May 1, 2010, 00:00

  • PMS54 RACIAL AND ETHNIC DISPARITIES IN TOTAL KNEE REPLACEMENT SURGERY

    May 1, 2010, 00:00

  • PCN39 MORTALITY COSTS FROM GENITAL CANCERS IN MEN-UNITED STATES, 2004

    May 1, 2010, 00:00

  • PDB53 IMPACT OF HYPOGLYCAEMIA ON PATIENT REPORTED OUTCOMES- A SYSTEMATIC LITERATURE REVIEW

    May 1, 2010, 00:00

  • PMH73 EVALUATION OF PSYCHOMETRIC EQUIVALENCE BETWEEN INTERACTIVE VOICE-RESPONSE (IVR) AND PAPER VERSIONS OF DAILY ASSESSMENT SCALE FOR ANXIETY (DAS-A)

    May 1, 2010, 00:00

  • PMH44 IMPACT OF ALTERNATIVE DEFINITIONS OF MEDICATION COMPLIANCE ON TREATMENT COST FOR MEDI-CAL PATIENTS WITH SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PCN86 COST-EFFECTIVENESS OF CETUXIMAB COMBINED WITH RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER IN TAIWAN

    May 1, 2010, 00:00

  • PHP111 IMPACT OF BLEEDING-RELATED COMPLICATIONS AND BLOOD PRODUCT TRANSFUSIONS ON HOSPITAL LENGTH OF STAY AND COSTS IN INPATIENT SURGICAL PATIENTS

    May 1, 2010, 00:00

  • PMH19 COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

    May 1, 2010, 00:00

  • PSY55 IS HOSPITAL EXPERIENCE ASSOCIATED WITH BETTER IN-HOSPITAL OUTCOMES AMONG SICKLE CELL PATIENTS WITH ACUTE CHEST SYNDROME- RESULTS FROM A NATIONAL DATABASE

    May 1, 2010, 00:00

  • PIN21 COST-EFFECTIVENESS OF THE ACIP RECOMMENDED ADULT IMMUNIZATION SCHEDULE IN THE US

    May 1, 2010, 00:00

  • PSY17 LITERATURE REVIEW OF THE ECONOMIC BURDEN OF IRON OVERLOAD ASSOCIATED WITH -THALASSEMIA, SICKLE CELL DISEASE, AND MYELODYSPLASTIC SYNDROMES IN THE UNITED STATES (US)

    May 1, 2010, 00:00

  • PHP58 ASSESSMENT OF PHARMACOECONOMIC EVALUATIONS SUBMITTED FOR REIMBURSEMENT SINCE KOREAN POSITIVE LIST SYSTEM INTRODUCTION

    May 1, 2010, 00:00

  • PCN70 ECONOMIC EVALUATION ON THE USE OF PLERIXAFOR ALONGSIDE THE GRANULOCYTE-COLONY STIMULATING FACTOR (GCSF) IN PREPARATION FOR AN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION ON PATIENTS WITH NON HODGKINS LYMPHOMA

    May 1, 2010, 00:00

  • PSY38 HEALTH-RELATED FAMILY FUNCTIONING IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-PATIENT INTERVIEWS SUPPORT SIX DOMAINS

    May 1, 2010, 00:00

  • PMH51 THE COST-EFFECTIVENESS OF EARLY RESPONDERS VERSUS EARLY NON-RESPONDERS TO ATYPICAL ANTIPSYCHOTIC THERAPY

    May 1, 2010, 00:00

  • PMC46 COMPARISON OF DIFFERENCE-IN-DIFFERENCE AND PROPENSITY SCORE METHODS IN REGRESSIONS WITH BINARY OUTCOMES

    May 1, 2010, 00:00

  • RM4 CONFOUNDING EFFECT OF AGE IN THE ASSOCIATION OF CARDIOVASCULAR RISK AND DIETARY SUPPLEMENT USE AMONG US ADULTS

    May 1, 2010, 00:00

  • PCN77 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN ROMANIA

    May 1, 2010, 00:00

  • PND27 CONFIRMATORY FACTOR ANALYSIS AND DIFFERENTIAL ITEM FUNCTIONING ANALYSIS OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE VERSION 2.1 IN CHRONIC MIGRAINEURS

    May 1, 2010, 00:00

  • PHP38 A FURTHER STUDY ON PREFERRED DRUG BENEFIT PLANS FOR CIVIL SERVANT MEDICAL BENEFIT SCHEME IN THAILAND

    May 1, 2010, 00:00

  • PSS18 THE IMPACT OF THE IPLEDGE PROGRAM ON ISOTRETINOIN FETAL EXPOSURE

    May 1, 2010, 00:00

  • PMS35 ASSESSING THE EQUIVALENCE OF ELECTRONIC AND PAPER DATA COLLECTION OF EQ-5D DATA IN RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PDB61 RACIAL AND ETHNIC DISPARITIES IN QUALITY OF HEALTH CARE AMONG ADULTS WITH DIABETES IN THE UNITED STATES IN 2005 AND 2006

    May 1, 2010, 00:00

  • CM4 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON HEALTH CARE UTILIZATION IN PATIENTS WITH COMORBID TYPE II DIABETES AND CARDIOVASCULAR DISEASE

    May 1, 2010, 00:00

  • PMS12 COST OF SECOND FRACTURE AMONG MEDICARE PATIENTS WITH INITIAL HIP, VERTEBRAL, AND NON-HIP NON-VERTEBRAL (NHNV) FRACTURES

    May 1, 2010, 00:00

  • PCN87 THE POTENTIAL IMPACT OF USING CHANGES IN SERUM HER2 LEVELS TO INITIATE THERAPY CHANGE IN HER2 METASTATIC BREAST CANCER

    May 1, 2010, 00:00

  • PGI6 TEMPORAL CHANGES IN SURGICAL PROCEDURES FOR MANAGEMENT OF DIVERTICULAR DISEASE

    May 1, 2010, 00:00

  • PCV129 INCREMENTAL HEALTH CARE EXPENDITURE AND RESOURCE UTILIZAION DUE TO CARDIOVASCULAR DISEASE AMONG PATIENS WITH CHRONIC OBSTRUCTIVE DISORDER IN THE HOSPITAL SETTING

    May 1, 2010, 00:00

  • PHP71 LISTING AND REIMBURSEMENT OF NEW DRUGS IN NATIONAL HEALTH INSURANCE-AN EMPIRICAL EXPERIENVCE OF TAIWAN

    May 1, 2010, 00:00

  • PHP5 UNCOVERING REASONS OF NON-COMPLIANCE IN EPRO STUDIES TO IMPROVE PRO DATA COLLECTION

    May 1, 2010, 00:00

  • PCV95 PREDICTIVE MODELS TO IDENTIFY NON-ADHERENCE TO DYSLIPIDEMIC MEDICATIONS USING PHARMACY AND MEDICAL CLAIMS DATA FROM A COMMERCIAL HEALTH PLAN

    May 1, 2010, 00:00

  • PND35 ANTIEPILEPTIC DRUG UTILIZATION AND MEDICAID REIMBUSEMENT TRENDS FROM 1991 TO 2008

    May 1, 2010, 00:00

  • PRS41 NATIONAL ANTI-ALLERGIC DRUG UTILIZATION PATTERNS IN ADULTS WITH ALLERGIC RHINITIS- NATIONAL AMBULATORY CARE SURVEY RESULTS.

    May 1, 2010, 00:00

  • PCN36 COST OF ILLNESS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER

    May 1, 2010, 00:00

  • PCN45 HEALTH CARE RESOURCE UTILIZATION (HRU) IN ADVANCED OVARIAN CANCER-FINDINGS FROM LINKED SEER-MEDICARE DATA

    May 1, 2010, 00:00

  • PND13 A SYSTEMATIC REVIEW OF ECONOMIC ANALYSES OF RASAGILINE AND ENTACAPONE IN PARKINSONS DISEASE

    May 1, 2010, 00:00

  • PHP19 PREVALENCE AND PREDICTORS OF ANTIDEPRESSANT PRESCRIBING IN ELDERLY NURSING HOME RESIDENTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PMC16 REVIEW OF COST EFFECTIVENESS STUDIES OF HIGH BUDGET IMPACT DRUGS

    May 1, 2010, 00:00

  • PDB17 THE HEALTH CARE COSTS OF LONG-ACTING INSULIN ANALOGS COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES USING A BASAL REGIMEN- A DANISH PERSPECTIVE

    May 1, 2010, 00:00

  • PND22 MAPPING FROM DISEASE-SPECIFIC MEASURES TO HEALTH-STATE UTILITY VALUES IN CHRONIC MIGRAINEURS

    May 1, 2010, 00:00

  • PR2 EVALUATING THE MEASUREMENT PROPERTIES OF AN AUGMENTED EQ-5D WITH THE INCLUSION OF TWO SINGLE QUALITY-OF-LIFE (QOL) INDICATORS USING THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS)

    May 1, 2010, 00:00

  • PCV26 THROMBOPROPHYLAXIS OF PATIENTS RECEIVING TOTAL HIP REPLACEMENT- 1998-2002 VERSUS 2003-2007

    May 1, 2010, 00:00

  • PRS36 NEED FOR IMPROVING ACCESS TO ESSENTIAL MEDICINES AND TREATMENT BEHAVIOUR TO BRONCHIAL ASTHMA A CHRONIC DISEASE

    May 1, 2010, 00:00

  • PHP74 RISK SHARING- WHATS BEING SHARED

    May 1, 2010, 00:00

  • PIN33 A CLINICAL-ECONOMIC STUDY OF CASPOFUNGIN THERAPY IN THE TREATMENT OF INVASIVE CANDIDIASIS IN RESUSCITATION AND INTENSIVE CARE UNITS

    May 1, 2010, 00:00

  • PCN128 SOCIAL DISPARITIES ACROSS THE CONTINUUM OF LUNG CANCER- A SYSTEMATIC REVIEW OF THE LITERATURE

    May 1, 2010, 00:00

  • PMH31 ASSESSING THE RISK OF HOSPITALIZATION AND ASSOCIATED HEALTH CARE COSTS IN PATIENTS WITH BIPOLAR DISORDER TREATED WITH ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PHP14 ACCESS WITH EVIDENCE DEVELOPMENT SCHEMES- A FRAMEWORK FOR THEIR DESIGN AND EVALUATION

    May 1, 2010, 00:00

  • PDB51 THE IMPACT OF NON-SEVERE HYPOGLYCEMIC EPISODES ON WORK PRODUCTIVITY AND DIABETES MANAGEMENT- A FOUR COUNTRY PERSPECTIVE

    May 1, 2010, 00:00

  • PCV66 COSTS ASSOCIATED WITH DISCHARGES AGAINST MEDICAL ADVICE IN A CVD POPULATION

    May 1, 2010, 00:00

  • PRS39 ASSESSING DEMOGRAPHIC DISPARITIES IN UTILIZATION OF INHALED CORTICOSTEROIDS AMONG PATIENTS WITH PERSISTENT ASTHMA

    May 1, 2010, 00:00

  • PND6 MODELING THE ESTIMATED COST-SAVINGS OF STRATIFIED CARE FOR MIGRAINE HEADACHES FROM A U.S. PERSPECTIVE

    May 1, 2010, 00:00

  • PCN114 EXPLORING THE BURDEN OF ILLNESS ON NEWLY DIAGNOSED ESOPHAGEAL CANCER PATIENTS IN TAIWAN -PRELIMINARY ANALYSIS

    May 1, 2010, 00:00

  • PCN27 ESTIMATED IMPACT OF EVEROLIMUS ON ANNUAL DRUG EXPENDITURE IN THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN A US HEALTH PLAN

    May 1, 2010, 00:00

  • PUK7 IMMUNOSUPPRESSANT THERAPY PATTERNS AND ITS COSTS IN POST KIDNEY TRANSPLANT PATIENTS IN THE NATIONAL TRANSPLANT PROGRAM IN BRAZIL

    May 1, 2010, 00:00

  • PIN25 COST-EFFECTIVENESS ANALYSIS OF ERTAPENEN VS THE PATTERS OF ANTIBIOTICS ROUTINELY USED FOR THE TREATMENT OF DIABETIC FOOT INFECTIONS AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2010, 00:00

  • PIN15 COST-EFFECTIVENESS OF THREE CARBAPENEMIC ANTI-INFECTIVES FOR TREATMENT OF VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN COLOMBIA

    May 1, 2010, 00:00

  • PMH15 PREDICTORS OF FAVORABLE LONG-TERM OUTCOME IN THE TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • HT2 VARIABILITY IN UTILIZATION OF INNOVATIVE DRUGS IN EUROPE AS A RESULT OF HEALTH TECHNOLOGY ASSESSMENT AND FUNDING PROCEDURES- EXAMPLES OF TRASTUZUMAB AND CETUXIMAB

    May 1, 2010, 00:00

  • PDB76 AN OPEN-SOURCE, INTERACTIVE MODEL TO ASSESS THE OUTCOMES AND ECONOMICS OF DIABETES INTERVENTIONS IN CANADA

    May 1, 2010, 00:00

  • PDB46 ADHERENCE TO STATIN THERAPY AMONG THE DIABETES PATIENTS AT A SELF-INSURED MID-WESTERN UNIVERSITY IN THE UNITED STATES

    May 1, 2010, 00:00

  • PHP6 QUANTITATIVE ANALYSIS OF THE INFLUENCE OF DISEASE AND PRODUCT CHARACTERISTICS ON ORPHAN DRUG PRICES IN EUROPE

    May 1, 2010, 00:00

  • PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

    May 1, 2010, 00:00

  • CASE2 INVENTING A TIERED FORMULARY BASED ON THE INCREMENTAL COST-EFFECTIVENESS OF DRUGS

    May 1, 2010, 00:00

  • PMH2 PATTERNS IN PRESCRIPTIONS OF ANTISYPCHOTICS FOR PATIENTS WITH MOOD DISORDERS AND THEIR OUTCOMES

    May 1, 2010, 00:00

  • PCN103 A REVIEW AND META-ANALYSIS OF COLORECTAL CANCER UTILITIES

    May 1, 2010, 00:00

  • PRS42 IMPACT OF THE UK PUBLIC SMOKING BAN ON THE PRESCRIBING OF SMOKING CESSATION THERAPY IN PRIMARY CARE^A THIN DATABASE STUDY

    May 1, 2010, 00:00

  • PHP56 IMPACT OF ENROLLING IN A CONSUMER-DRIVEN HEALTH PLAN (CDHP) ON MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PCV115 A SYSTEMATIC REVIEW OF QUALITY OF LIFE ASSESSMENT OF PATIENTS SUFFERING FROM THORACIC AORITC DISEASES

    May 1, 2010, 00:00

  • ME1 CLINICAL, ECONOMIC, AND HUMANISTIC BENEFITS OF A RHEUMATOID ARTHRITIS DISEASE THERAPY MANAGEMENT PROGRAM

    May 1, 2010, 00:00

  • PGI34 TREATMENT SATISFACTION WITH MEDICATIONS FOR GASTROESOPHAGEAL REFLUX DISEASE- RESULTS FROM A LARGE DISEASE REGISTRY

    May 1, 2010, 00:00

  • PMS68 DOSES AND INFUSION INTERVALS FOR INFLIXIMAB IN ANTI-TNF NAiVE AND ANTI-TNF EXPERIENCED MANAGED CARE PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PCV77 COST EFFECTIVENESS ANALYSIS THE PREVENTION OF VENOUS THROMBOEMBOLISM IN IMMOBILIZED PATIENTS (PREVENT) TRIAL- THROMBOPROPHYLACTIC TREATMENT WITH DALTEPARIN VERSUS PLACEBO IN ACUTELY ILL PATIENTS

    May 1, 2010, 00:00

  • PCN41 HEALTH CARE COST OF BREAST CANCER- A CLAIMS DATA ANALYSIS

    May 1, 2010, 00:00

  • PIH31 A STUDY OF THE EFFECT OF MEDICAID COVERAGE ON CHILDRENS HEALTH

    May 1, 2010, 00:00

  • PDB56 RELATIONSHIP BETWEEN CARE FINANCING STRUCTURE AND DIABETES CARE ASSESSMENTS AMONG MEDICAID BENEFICIARIES WITH TYPE 2 DIABETES

    May 1, 2010, 00:00

  • PCV99 THE ROLE OF ILLNESS BURDEN AND MEDICATION BELIEFS IN MEDICATION COMPLIANCE OF ELDERLY WITH HYPERTENSION

    May 1, 2010, 00:00

  • PDB73 QUALITY OF CARE FOR DIABETICS IN KARACHI PAKISTAN

    May 1, 2010, 00:00

  • PSY39 WHAT ARE THE KEY ATTRIBUTES AND ENDPOINTS OF OVERWEIGHT AND OBESITY THERAPY? A CONCEPTUAL MAP OF PATIENT-CENTRED OUTCOMES

    May 1, 2010, 00:00

  • PMC18 ELECTRONIC PRO VERSUS PAPER PRO- WHAT DO THE PATIENTS THINK?

    May 1, 2010, 00:00

  • PCV2 POSTMARKETING SAFETY EVALUATION OF ALISKIREN HEMIFUMARATE, A NEW MOLECULAR ENTITY

    May 1, 2010, 00:00

  • PMS10 THE INDIRECT COSTS ASSOCIATED WITH ABSENTEEISM OF WORKING ADULTS WITH RHEUMATOID ARTHRITIS- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PMH92 TIME SERIES ANALYSIS TO EXAMINE THE EFFECT OF GUIDELINES

    May 1, 2010, 00:00

  • PMH18 TREATMENT PATTERNS IN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANALYSES WITH THE RAMQ DATABASE

    May 1, 2010, 00:00

  • PCV122 IS PRESCRIBING JUSTIFIED BY THE EVIDENCE?-COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS FOR TREATING HYPERTENSIVE OUTPATIENTS IN SOUTHERN TAIWAN

    May 1, 2010, 00:00

  • PCV80 ECONOMIC ANALYSIS OF ENOXAPARIN IN COMPARISON WITH FONDAPARINUX IN THE TREATMENT OF DEEP-VEIN THROMBOSIS (DVT)

    May 1, 2010, 00:00

  • PCN125 NUMBER OF DOCETAXEL TREATMENT CYCLES AND OVERALL SURVIVAL FOR METASTATIC PROSTATE CANCER-RESULTS FROM A US LOCAL COMMUNICTY PRACTICE

    May 1, 2010, 00:00

  • PIN34 COST MINIMIZATION ANALYSIS OF THREE CANDIDA IDENTIFICATION TESTS WITH PREDICTION MODELS BASED ON REAL-WORLD DATA

    May 1, 2010, 00:00

  • PCV28 TEN-YEAR TRENDS IN STATIN USE AMONG ELDERLY WOMEN

    May 1, 2010, 00:00

  • PMH10 LONG-TERM OUTCOMES AFTER SWITCHING FROM TYPICAL ANTIPSYCHOTICS TO OLANZAPINE AMONG SCHIZOPHRENIA PATIENTS IN JAPAN

    May 1, 2010, 00:00

  • PCN116 PILOT STUDY FOR EVULATION OF OUTCOMES OF BREAST CANCER WITH SPECIAL FOCUS ON ECONOMIC IMPACT AND QUALITY OF LIFE

    May 1, 2010, 00:00

  • PCV15 BLOOD PRESSURE GOAL ACHIEVEMENT AMONG HYPERTENSION PATIENTS TREATED WITH VALSARTAN-BASED SINGLE PILL COMBINATION VS. ARB-BASED FREE COMBINATION IN SOUTH CENTRAL REGION

    May 1, 2010, 00:00

  • PCN133 A SUCCESSFUL ADOPTION OF PERSONALIZED MEDICINE- EXAMPLE OF KRAS MUTATIONAL ANALYSIS

    May 1, 2010, 00:00

  • PRS11 PREDICTORS OF ANTIHISTAMINE PRESCRIPTION IN THE NATIONAL AMBULATORY POPULATION WITH ALLERGIC RHINITIS

    May 1, 2010, 00:00

  • PCN29 REAL WORLD DATA ON MULTIFRACTION (MFR) VERSUS SINGLE FRACTION (SFR) RADIOTHERAPY TO TREAT BONE METASTASIS- IMPACT IN COSTS FOR PRIVATE HEALTH CARE (PHC) PROVIDERS IN BRAZIL

    May 1, 2010, 00:00

  • PMH6 NURSING HOME USE OF ATYPICAL ANTIPSYCHOTICS FOR BEHAVIORAL AND PSYCHOLOGICAL PROBLEMS OF ELDERLY WITH DEMENTIA- A SYSTEMATIC REVIEW

    May 1, 2010, 00:00

  • PCV81 DRUG-ELUTING STENTS VERSUS BARE-METAL STENTS FOR ACUTE MYOCARDIAL INFARCTION- AN ECONOMIC ANALYSIS APPROACH

    May 1, 2010, 00:00

  • PHP18 EVALUATION OF MEDICARE PART D PHARMACY AND MEDICAL UTILIZATION PATTERNS BY COVERAGE PHASE FOR COMMON CHRONIC DISEASES

    May 1, 2010, 00:00

  • PMS51 PRESCRIPTION PATTERNS AND EXPENDITURE OF ANTI-TNG AGENTS IN RHEUMATOID PATIENTS IN TAIWAN

    May 1, 2010, 00:00

  • PMH47 THE ECONOMIC IMPACT OF ARIPIPRAZOLE AMONG PERSONS WITH SCHIZOPHRENIA IN MEXICO

    May 1, 2010, 00:00

  • PCV107 PATIENT ADHERENCE TO CHRONIC DISEASE MEDICATIONS IN A MEDICATION THERAPY MANAGEMENT PROGRAM

    May 1, 2010, 00:00

  • PRS1 A COMPARISON OF CLINICAL PROFILES, MEDICATION USE AND SYMPTOMOLOGY IN ASTHMA PATIENTS PRESCRIBED LOW/MODERATE DOSE FLUTICASONE PROPIONATE/SALMETEROL OR MODERATE/HIGH DOSE FLUTICASONE PROPIONATE

    May 1, 2010, 00:00

  • PCV35 SEASONAL VARIATION AND INFLUENCE OF METEOROLOGICAL FACTORS IN CASE OF ACUTE CEREBROVASCULAR EVENTS

    May 1, 2010, 00:00

  • PSY60 LARGE-SCALE, PROSPECTIVE, OBSERVATIONAL STUDIES IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS- A SYSTEMATIC AND CRITICAL REVIEW.

    May 1, 2010, 00:00

  • PSY31 CLINICAL-ECONOMIC EVALUATION OF AZACITIDINE VERSUS DECITABINE FOR TREATING PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

    May 1, 2010, 00:00

  • PRS5 COMORBIDITIES, QUALITY OF LIFE, AND HEALTH CARE ACCESS BY RISK COHORT CHARACTERISTICS OF PEOPLE CALCULATED USING FRAMINGHAM RISK PERCENT FROM THE US NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES)

    May 1, 2010, 00:00

  • PSS15 COMPARISON OF THE PRO ENDPOINTS FOUND IN LABELING CLAIMS OF PRODUCTS FOR THE TREATMENT OF PSORIASIS WITH THOSE RECOMMENDED BY THE CORRESPONDING EMEA GUIDANCE

    May 1, 2010, 00:00

  • PMH17 OUTCOME TRAJECTORIES IN THE LONG-TERM TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PDB65 IMPROVED PATIENT OUTCOMES RESULTING FROM PHYSICIANS* THERAPY DECISIONS BASED ON PHARMACISTS RECOMMENDATIONS

    May 1, 2010, 00:00

  • PHP80 THE STATE OF HEALTH ECONOMICS AND PHARMACEOCONOMICS EVALUATION RESEARCH IN NIGERIA- A SYSTEMATIC REVIEW

    May 1, 2010, 00:00

  • PMH53 ESTIMATION OF UTILITY GAINED FROM METHADONE MAINTENANCE TREATMENT FOR OPIOID DEPENDENCE

    May 1, 2010, 00:00

  • PMC6 USE OF CLINICAL SIMULATION CENTERS TO CONDUCT PATIENTCENTERED TIME-AND-MOTION SIMULATIONS AS A BASIS FOR ECONOMIC ANALYSIS

    May 1, 2010, 00:00

  • PGI10 PATIENT FINANCIAL BURDEN, SURGICAL COSTS AND REIMBURSEMENTS FOR OPEN AND LAPAROSCOPIC COLECTOMY PROCEDURES IN DIVERTICULAR DISEASE

    May 1, 2010, 00:00

  • PHP30 A DESCRIPTIVE EXAMINATION OF MARIJUANA AND COCAINE USE AMONG EMPLOYED PERSONS AND ITS ASSOCIATION WITH WORK DAYS SKIPPED AND HEALTH STATUS

    May 1, 2010, 00:00

  • PIN42 DRG-BASED HOSPITAL PAYMENT SYSTEM IMPACT ON MEDICAL DECISION MAKING

    May 1, 2010, 00:00

  • PMC13 THE COST-EFFECTIVENESS SENSITIVITY CURVE- QUANTIFYING THE EFFECT OF INDIVIDUAL PARAMETER UNCERTAINTY IN A PROBABILISTIC MODEL

    May 1, 2010, 00:00

  • PHP55 A SHORT 10-ITEM MEASURE OF COLLABORATIVE CLINICAL TEAM WORKING- THE WORKING IN HEALTH CARE QUESTIONNAIRE (WHQ-10)

    May 1, 2010, 00:00

  • PRS2 A NOVEL METHODOLOGY FOR MEASURING THE INFLUENCE OF COMORBIDITY IN HEALTH OUTCOME STUDIES

    May 1, 2010, 00:00

  • PUK21 POST-KIDNEY TRANSPLANT MORBIDITY RELATED RE-HOSPITALIZATIONS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM- CAUSES, RESOURCES USE AND COSTS BASED ON AN ADMINISTRATIVE REGISTRY REVIEW FROM 2004 TO 2009

    May 1, 2010, 00:00

  • PDB66 EVALUATION OF SELECTED COMPREHENSIVE DIABETES CARE MEASURES IN A MANAGED CARE DATABASE BY USING THE RETROSPECTIVE ANALYSIS FOR DIABETES ACTION AND REPORTING TOOL

    May 1, 2010, 00:00

  • PSY53 INTRAGASTRIC BALOON (IGB) FOR MORBIDLY OBESE (MOP) AND SUPER OBESE PATIENTS (SOP) - SYSTEMATIC REVIEW (SR) AND HEALTH TECHNOLOGY ASSESSMENT (HTA)

    May 1, 2010, 00:00

  • PUK3 EVALUATION OF SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION VERSUS LIVER TRANSPLANTATION ALONE FOR END-STAGE LIVER DISEASE PATIENTS WITH IMPAIRED RENAL FUNCTION - A COMPARATIVE EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • PMS56 ACCESS TO BIOLOGIC TREATMENT IN RHEUMATOID ARTHRITIS IN CENTRAL AND EASTERN EUROPEAN (CEE) COUNTRIES

    May 1, 2010, 00:00

  • DISCLOSURE INFORMATION

    May 1, 2010, 00:00

  • PHP4 IMPROVING ACCESS-TO-CARE LEADS TO OPTIMAL OUTCOMES IN PHARMACIST-LED MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM

    May 1, 2010, 00:00

  • PCN81 THE COST-EFFECTIVENESS ANALYSIS OF SEMI-ANNUAL SCREENING FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHORNIC HEPATITIS B

    May 1, 2010, 00:00

  • PRS10 INCIDENCE RATE AND MAJOR CAUSES OF PROLONGED MECHANICAL VENTILATION IN TAIWAN- A POPULATION-BASED STUDY DURING 1997-2007

    May 1, 2010, 00:00

  • PMC39 TAPPING INTO A NEW DATA COLLECTION PARADIGM- USING DIRECT TO PATIENT PROGRAMS FOR MORE COST EFFECTIVE STUDY MANAGEMENT

    May 1, 2010, 00:00

  • PCN106 IMPACT OF AN INDIVIDUALS LOCUS OF CONTROL ON UTILITY VALUES FOR HEAD AND NECK CANCER HEALTH STATES

    May 1, 2010, 00:00

  • PDB12 PREDICTORS OF STATIN USE AMONG OVERWEIGHT AND OBESE ADULTS IN AMBULATORY CARE SETTING IN THE UNITED STATES

    May 1, 2010, 00:00

  • PHP10 COST CONSEQUENCE ANALYSIS OF PRESCRIPTION DRUG LABEL CHANGES

    May 1, 2010, 00:00

  • CE1 COST-EFFECTIVENESS OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING- A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY

    May 1, 2010, 00:00

  • PMC34 SUPPLEMENTAL METHODOLOGY FOR TRANSLATING INSTRUMENTS DEVELOPED IN A LANGUAGE OTHER THAN ENGLISH

    May 1, 2010, 00:00

  • PHP100 INDEPENDENT RETAIL PHARMACY ATTRIBUTES, INSURER REIMBURSEMENT, AND THE IMPLICATION ON THE PROPOSED COLLECTIVE BARGAINING LAW

    May 1, 2010, 00:00

  • PND33 PREDICTORS OF PAIN MEDICATION SELECTION AMONG PATIENTS DIAGNOSED WITH FIBROMYALGIA

    May 1, 2010, 00:00

  • PCV21 A BENEFIT-RISK ASSESSMENT OF USING CYP2C19 GENOTYPE INFORMATION TO GUIDE ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME

    May 1, 2010, 00:00

  • PMH61 ADHERENCE AND PERSISTENCE WITH MEDICATION THERAPY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER- A REAL-WORLD COMPARISON OF BRANDED ANTIDEPRESSANTS AND GENERIC SSRIS

    May 1, 2010, 00:00

  • PCASE5 DEVELOPMENT OF A COOPERATIVE PHYSICIAN-PHARMACIST MEDICATION THERAPY MANAGEMENT MODEL FOR THE POLYPHARMACY ELDERLY IN TAIWAN

    May 1, 2010, 00:00

  • PRS3 THE PREVALENCE OF COMORBID CONDITIONS IN U.S. PATIENTS DIAGNOSED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

    May 1, 2010, 00:00

  • PDB24 COST-EFFECTIVENESS OF ROUX-EN-Y GASTRIC BYPASS IN TYPE 2 DIABETES PATIONTS IN CANADA

    May 1, 2010, 00:00

  • PGI30 PSYCHOMETRIC PROPERTIES OF THE TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

    May 1, 2010, 00:00

  • PCN85 ECONOMIC MODELING FOR TREATMENT FAILURE PATIENTS USING MULTIPLE ROUNDS OF THERAPY AS COMPARATOR- CASE IN POINT LYMPHOMA DRUG CANDIDATE

    May 1, 2010, 00:00

  • PSY20 COMPARISON OF DOSING PROFILES BETWEEN DULOXETINE AND PREGABALIN INITIATORS AMONG ELDERLY PATIENTS WITH FIBROMYALGIA

    May 1, 2010, 00:00

  • PDB59 TIME TO OPIOID USE AMONG COMMERCIALLY-INSURED PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS

    May 1, 2010, 00:00

  • PIN31 COST-EFFECTIVENESS OF THREE ANTIRETROVIRAL SCHEMES AFTER A FIRST VIROLOGICAL FAILURE IN PATIENTS WITH HIV/AIDS IN COLOMBIA

    May 1, 2010, 00:00

  • PCV89 COST EFFECTIVENESS OF PRASAGREL OR CHOPIDOGREL FOR TREATMENT OF ACS PATIENTS BASED ON GENETIC TESTING FOR CYP2C19 VARIANTS

    May 1, 2010, 00:00

  • PMS53 UTILISATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN QUEBEC, CANADA- IS THERE A CHANGE IN THE PATIENT RISK PROFILE AFTER THE WITHDRAWAL OF ROFECOXIB?

    May 1, 2010, 00:00

  • PCV155 LINKING CLAIMS AND ELECTRONIC MEDICAL RECORD (EMR) DATA FOR A HYPERTENSION STUDY

    May 1, 2010, 00:00

  • PSS9 EFFICIENCY (COST/EFFICACY) OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS

    May 1, 2010, 00:00

  • PHP43 PROCEDURES WITH THE MOST RAPIDLY INCREASING HOSPITAL COSTS, 2004-2007

    May 1, 2010, 00:00

  • PSY35 PERSISTENCE AND COMPLIANCE OF DEFEROXAMINE VERSUS DEFERASIROX IN MEDICAID PATIENTS WITH SICKLE-CELL DISEASE (SCD)

    May 1, 2010, 00:00

  • PHP53 PATIENTS USING SPECIALTY PHARMACIES FOR A TUMOR NECROSIS FACTOR ANTAGONIST HAD GREATER REFILL ADHERENCE THAN THOSE USING A RETAIL PHARMACIES

    May 1, 2010, 00:00

  • PMH88 ASSOCIATION OF PATIENT CHARACTERISTICS WITH THE USE OF PHARMACOTHERAPY, PSYCHOTHERAPY AND COMBINED TREATMENT FOR DEPRESSION

    May 1, 2010, 00:00

  • PMH59 SYSTEM DYNAMICS SIMULATION FOR ACUTE SCHIZOPHRENIA TREATMENT

    May 1, 2010, 00:00

  • PCN108 PSYCHOMETRIC VALIDATION OF A PATIENT QUESTIONNAIRE EVALUATING SATISFACTION WITH A DARBEPOETIN ALPHA PRE-FILLED DEVICE FOR SELF-INJECTION (ARANESPSURECLICKTMDEVICE), AND A HOME-SERVICE (2CARESERVICE) IN CHEMOTHERAPY-INDUCED ANAEMIC CA ...

    May 1, 2010, 00:00

  • PMS76 DERIVING SEVERITY INDEX FOR RHEUMATOID ARTHRITIS FROM HEALTH CARE CLAIMS DATA

    May 1, 2010, 00:00

  • PMS74 USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS- MAPPING WOMAC ONTO THE EQ-5D UTILITY INDEX

    May 1, 2010, 00:00

  • DB1 DEVELOPMENT AND VALIDATION OF A MODEL TO PREDICT VIROLOGIC FAILURE USING ADMINISTRATIVE CLAIMS

    May 1, 2010, 00:00

  • PGI1 ASSOCIATION OF WARFARIN, NSAIDS, AND GASTROINTESTINAL BLEED

    May 1, 2010, 00:00

  • PMS21 COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PCN141 USING A DISEASE MANAGEMENT APPROACH IN A HEALTH TECHNOLOGY ASSESSMENT- A CASE STUDY

    May 1, 2010, 00:00

  • PUK20 ECONOMIC EVALUATION OF THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN COLOMBIA

    May 1, 2010, 00:00
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146 (current)
  • 147
  • 148
  • 149
  • 150
  • »